-
ECB holds rates steady after Lagarde says to quit early
-
US economy posts strong growth, inflation stubbornly high in challenge to Trump
-
ECB chief Lagarde to step down early, triggering succession race
-
French businessman takes over 2030 Winter Olympics amid leadership turmoil
-
VW says 'no time to lose' to slash costs after 5.8 billion euro loss
-
Stock markets diverge on corporate earnings, tech jitters
-
Oil majors reap bumper profits as Mideast war drives prices
-
TotalEnergies profit hits record on high oil prices
-
Taiwan says Pakistan briefly closed airspace to Taiwanese flights
-
Afghanistan opium poppy cultivation surges despite Taliban govt ban: UN
-
Samsung logs record quarterly profits despite investor AI jitters
-
Microsoft beats expectations fueled by Azure cloud business
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US Fed holds interest rates steady despite 'too high' inflation
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
US labor leader Dolores Huerta dead: family
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
-
French firm Safran helps build aircraft wings of the future in UK factory
-
Canada hikes rates to contain oil price surge caused by Iran war
-
World Bank warns of worsening food insecurity as commodity prices soar
Covid vaccines may cause period problems, experts warn
Some Covid vaccines may cause heavy menstrual bleeding, specialists at the European Medicines Agency (EMA) warned Friday, recommending that this be added to the list of potential side-effects.
"Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty (Pfizer) and Spikevax (Moderna)," said a statement from the agency, citing its drugs safety committee.
Having reviewed the data, they concluded that "there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines".
They thus recommended that this be added to the product information of the two mRNA Covid-19 vaccines.
"There is no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility," the EMA statement added.
The safety committee also stressed that "the benefits of these vaccines greatly outweigh the risks".
The instances of heavy menstrual bleeding have been monitored at both national and European level since the first reports appeared among vaccinated women.
France's National Medicine Safety Agency (ANSM) started interviewing women about the issue in July, passing their findings to the EMA.
So far, however, researchers have not established a causal connection beyond any doubt.
The reported issues mainly concern changes to the length and intensity of the menstrual bleeding, which are sometimes more painful.
While in most cases the symptoms experienced were "not serious" and transitory, some women experienced the symptoms for up to six months, the ANSM reported.
The French agency is continuing to research the issue.
M.Anderson--CPN